Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Substance Use Disorders Clinical Trials

100 recruiting trials for Substance Use Disorders. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
4
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05156112

OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit

Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional...

Sponsor: VA Office of Research and DevelopmentEnrolling: 1941 location
RECRUITINGNCT06790641

Pathways to Perinatal Mental Health Equity

Mental health conditions occurring during pregnancy and up to one year postpartum (the perinatal period) occur in 1 in 5 perinatal individuals. To improve mental health care...

Sponsor: University of Massachusetts, WorcesterEnrolling: 12701 location
RECRUITINGNCT05814822

Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use

This study will compare the efficacy of telemedicine-delivered cognitive behavioral therapy for insomnia tailored for people using cannabis for sleep (CBTi-CB-TM) to...

Sponsor: University of MichiganEnrolling: 2001 location
RECRUITINGPhase 3NCT05589181

High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)

This project, involving two distinct clinical trials, tests whether induction to a higher than currently recommended buprenorphine (BUP) induction dose is safe and can improve the...

Sponsor: Rutgers, The State University of New JerseyEnrolling: 1401 location
RECRUITINGNCT06216600

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and comittment therapy(ACT) + exercise...

Sponsor: University of California, San DiegoEnrolling: 3001 location
RECRUITINGNCT06835907

Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study

The goal of this clinical trial is to determine the efficacy of baclofen for the treatment of alcohol use disorder (AUD) in patients with or without comorbid anxiety symptoms. The...

Sponsor: Universitair Ziekenhuis BrusselEnrolling: 581 location
RECRUITINGPhase 2 / Phase 3NCT05011266

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

This study will evaluate the effectiveness of a new pharmacological approach to increase efficacy of treatment with extended release naltrexone (XR-naltrexone) for individuals...

Sponsor: New York State Psychiatric InstituteEnrolling: 1802 locations
RECRUITINGPhase 2NCT05790239

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose...

Sponsor: Stephen Robert MarderEnrolling: 402 locations
RECRUITINGPhase 2NCT06651177

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

The primary objective of this research study is to evaluate the effect of tirzepatide, relative to placebo, as an adjunct to BUP on retention, substance use, and sleep outcomes in...

Sponsor: T. John Winhusen, PhDEnrolling: 31010 locations
RECRUITINGNCT06350409

Adolescent Outcomes of Post-operative Opioid EXposure

The goal of this observational study is to examine the factors associated with the transition from medical exposure to opioids with "signposts" of future opioid use disorder among...

Sponsor: Sharon LevyEnrolling: 200005 locations
RECRUITINGNCT06218706

LIFU for Treatment for Refractory Opioid Use Disorder

This is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.

Sponsor: Ali RezaiEnrolling: 341 location
RECRUITINGPhase 1 / Phase 2NCT05548452

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol...

Sponsor: Virginia Commonwealth UniversityEnrolling: 802 locations
RECRUITINGNCT04927143

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

Combatting the rise of the opioid epidemic is a central challenge of U.S. health care policy. A promising approach for improving welfare and decreasing medical costs of people...

Sponsor: Wake Forest University Health SciencesEnrolling: 6002 locations
RECRUITINGNCT06559774

The Hastiin Bidziil (Strong Man) Intervention

The Hastiin Bidziil (Strong man) Intervention study is part of a larger project called, Community-Driven Indigenous Research, Cultural Strengths \& Leadership to Advance Equity in...

Sponsor: Johns Hopkins Bloomberg School of Public HealthEnrolling: 1602 locations
RECRUITINGNCT04610697

Cognitive Remediation in Forensic Mental Health Care

Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One...

Sponsor: The Royal Ottawa Mental Health CentreEnrolling: 301 location
RECRUITINGNCT06446349

Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic...

We hypothesise that a short-term intervention by dispensing pharmacists is feasible and relatively easy to implement, and that it could have an impact on the deprescribing of...

Sponsor: University Hospital, GrenobleEnrolling: 30020 locations
RECRUITINGNCT06413979

Family Support Protocol for Adolescent Internalizing Disorders

This R34 will develop and test an adjunctive treatment protocol for addressing co-occurring internalizing disorders among adolescents enrolled in usual care for substance use...

Sponsor: The National Center on Addiction and Substance Abuse at Columbia UniversityEnrolling: 604 locations
RECRUITINGNCT06367348

An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

With a full-scale randomized control trial, the investigators will evaluate the efficacy and cost effectiveness of Mlambe, an economic and relationship-strengthening intervention...

Sponsor: University of California, San FranciscoEnrolling: 5001 location
RECRUITINGNCT05492825

IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

This is a pragmatic, open label, randomized controlled trial with 1:1:1 allocation to 12 weeks of: (1) onsite yoga at opioid treatment programs (OTPs), (2) onsite physical therapy...

Sponsor: Albert Einstein College of MedicineEnrolling: 1801 location
RECRUITINGNCT07020273

CONNECT Cancer Survivors With Tobacco Treatment

The purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving...

Sponsor: Washington University School of MedicineEnrolling: 50001 location
RECRUITINGPhase 2NCT05452772

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

This is a multi-site, double-blind, randomized clinical trial of the 5-HT2A receptor agonist psilocybin for smoking cessation. Four sites with experience in conducting psilocybin...

Sponsor: Johns Hopkins UniversityEnrolling: 663 locations
RECRUITINGPhase 2NCT05781009

Pregnenolone for the Treatment of Alcohol Use Disorder

This Phase 2 randomized cotrolled trial (RCT) will assess the safety and efficacy of pregnenolone (PREG; 300 mg/day, b.i.d dosing) vs. placebo (PBO) over a 12 week treatment...

Sponsor: Yale UniversityEnrolling: 1501 location
RECRUITINGNCT07341230

Deep Brain Stimulation to Understand and Treat Addiction

This study is testing whether deep brain stimulation (DBS) can safely help people with severe alcohol use disorder who have not improved with standard treatments. DBS uses small...

Sponsor: University of CambridgeEnrolling: 92 locations
RECRUITINGNCT06211959

Evaluating the Effectiveness of Implementation Intentions to Strengthen Approach-avoidance Training

Approach Bias Modifcation corresponds to computerized interventions designed to change a cognitive bias (i.e., the approach bias) that may contribute to the maintenance of Alcohol...

Sponsor: Clinique de la MitterieEnrolling: 1121 location
RECRUITINGNCT07071779

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

Substance misuse is one of the most common risk factors for health problems and premature death among adolescents and young adults worldwide. Although there are effective...

Sponsor: University of BernEnrolling: 2101 location
RECRUITINGPhase 4NCT07199335

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

The goal of this study is to determine the feasibility and impact of delivering long-acting injectable cabotegravir HIV pre-exposure prophylaxis and suite of support services to...

Sponsor: Massachusetts General HospitalEnrolling: 1002 locations
RECRUITINGPhase 2NCT05870111

Citicoline in Youth Alcohol Use Disorder

The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and...

Sponsor: Medical University of South CarolinaEnrolling: 561 location
RECRUITINGPhase 2NCT06614504

Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes

Cigarette smoking remains the leading cause of preventable morbidity and mortality in the US. Use of multiple tobacco products is becoming increasingly prevalent, with dual use of...

Sponsor: University of VermontEnrolling: 3082 locations
RECRUITINGPhase 1NCT05487807

Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia

This proposal tests the efficacy of a phone-based tobacco cessation intervention for people living with HIV (PLWH) in comparison to the standard of care (brief advice to quit) and...

Sponsor: University of Southern CaliforniaEnrolling: 8002 locations
RECRUITINGNCT06881069

Reach Through Equitable Implementation in Utah

The goal of this pragmatic, multilevel Type III Hybrid Effectiveness-Implementation trial is to increase the reach of existing evidence-based interventions (EBIs) for tobacco...

Sponsor: University of UtahEnrolling: 15601 location
RECRUITINGPhase 3NCT03912194

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study...

Sponsor: University of Alabama at BirminghamEnrolling: 4001 location
RECRUITINGNCT06678672

Contingency Management for Veteran Smokers Undergoing Major Elective Surgery

The goal of this study is to design and test the first mobile contingency management (CM) smoking cessation intervention for military Veterans undergoing major elective surgery....

Sponsor: University of California, San FranciscoEnrolling: 361 location
RECRUITINGNCT06678789

Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches

Tobacco-free oral nicotine pouches (such as Zyn brand) are a less harmful alternative to cigarette smoking. Pouches, however, contain nicotine, and addictive substance that is not...

Sponsor: Medical University of South CarolinaEnrolling: 501 location
RECRUITINGPhase 2NCT06521476

Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder

Patients with opioid use disorder treated with either methadone or buprenorphine are at risk of developing central sleep apnea (CSA) from these medications. Investigators will...

Sponsor: Sanjay R PatelEnrolling: 401 location
RECRUITINGNCT05836090

Family Spirit Strengths

This project addresses the disproportionate morbidity and mortality associated with mental and behavioral health problems in American Indian and Alaska Native communities. Access...

Sponsor: Johns Hopkins Bloomberg School of Public HealthEnrolling: 1883 locations
RECRUITINGNCT05913518

Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications:...

Addressing cognitive deficits in alcohol use disorder (AUD) supports recovery. Impaired metacognitive functioning in AUD causes compromised recognition of the interoceptive state...

Sponsor: Brugmann University HospitalEnrolling: 1301 location
RECRUITINGPhase 2NCT06969937

Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol...

The goal of this clinical trial is to learn about the effects of the combination of ketamine and realtime functional magnetic resonance imaging (fMRI) neurofeedback training on...

Sponsor: Dr. med. Marcus HerdenerEnrolling: 751 location
RECRUITINGNCT06643988

Autobiographical Memory in Opioid Use Disorder

The research study is being conducted to better understand memory function in people with opioid use disorder (OUD) and whether memory training can improve the symptoms and lives...

Sponsor: University of PennsylvaniaEnrolling: 301 location
RECRUITINGNCT06415721

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Alcohol Use Disorders are currently positioned as the third leading cause of preventable death in the United States, constituting a humanitarian crisis with substantial financial...

Sponsor: VA Palo Alto Health Care SystemEnrolling: 401 location
RECRUITINGNCT06675539

Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)

The goal of this observational study is to validate the French version of the PAWSS scale in a population of patients with Alcohol Use Disorders. Prediction of Alcohol Withdrawal...

Sponsor: Etablissement Public de Santé Barthélemy DurandEnrolling: 5451 location
RECRUITINGEarly Phase 1NCT05665465

Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking

The purpose of this study is to evaluate how certain childhood experiences influences brain function and responses to nicotine exposure in a group of nonsmoking young adults. The...

Sponsor: Duke UniversityEnrolling: 1501 location
RECRUITINGPhase 1 / Phase 2NCT05513872

Overcoming Nicotine Dependence to Enable Quitting

Tobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly...

Sponsor: Rush University Medical CenterEnrolling: 7801 location
RECRUITINGNCT06488443

Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals

Yoga is a culturally acceptable practice that can reduce craving and help people quit tobacco. There is a need to evaluate the feasibility of implementation of a well- designed...

Sponsor: University of PittsburghEnrolling: 961 location
RECRUITINGNCT05534815

Long-Term Treatment of Opioid Use Disorder

Poverty and opioid addiction are interrelated and chronic problems which have not been addressed adequately. The Therapeutic Workplace could treat the many adults with opioid use...

Sponsor: Northern Michigan UniversityEnrolling: 2251 location
RECRUITINGPhase 1NCT06920238

Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

The goal of this clinical trial is to learn if Therabot-CALM (Cannabis, Anxiety, Low Mood) has acceptability among users and could work to improve the symptoms of persons with...

Sponsor: Trustees of Dartmouth CollegeEnrolling: 151 location
RECRUITINGNCT06345274

MBC2OTP Project (Measurement-Based Care Implementation in Community Opioid Treatment Programs)

The goal of this clinical trial is to evaluate the effectiveness and implementation of measurement-based care, which involves the systematic use of client self-report data to...

Sponsor: Northwestern UniversityEnrolling: 405 locations
RECRUITINGNCT07262190

NavSTAR Implementation Effectiveness Trial Across a Health System

Patient Navigation (PN) interventions following hospitalization can improve outcomes for people with opioid use disorder treatment. Delivering PN interventions on a wide scale...

Sponsor: Friends Research Institute, Inc.Enrolling: 7201 location
RECRUITINGPhase 2NCT06441604

Extended-release Buprenorphine as a Novel Low-dose Induction Strategy

This is a clinical trial to characterize the safety and pharmacokinetics of using extended-release buprenorphine (XR-BUP) as a novel low-dose buprenorphine induction strategy....

Sponsor: Brigham and Women's HospitalEnrolling: 301 location
RECRUITINGNCT06646692

Mindful Self-Compassion to Address PTSD and Substance Use in Unhoused Women

Trauma exposure, posttraumatic stress disorder (PTSD), and substance use disorder (SUD) present major threats to public health. PTSD and SUD are major correlates of disability,...

Sponsor: University of California, Los AngelesEnrolling: 2021 location
RECRUITINGNCT06923423

Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons

Addiction and trauma exposure are common among the 5.5 million people (1 in 47 adults) in the U.S. who are in prison or under supervision. About 85% of people in prison have a...

Sponsor: University of ArkansasEnrolling: 6406 locations

Showing 50 of 100 trials.Search all Substance Use Disorders trials

Frequently Asked Questions

There are currently 100 clinical trials for Substance Use Disorders, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Substance Use Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 4 Phase 3 trials for Substance Use Disorders, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.